Axon Enterprise, Inc. (NASDAQ:AXON) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) have been assigned an average rating of “Moderate Buy” from the thirteen research firms that are covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $231.27.

Several research analysts have recently commented on the company. Barclays lifted their target price on Axon Enterprise from $222.00 to $256.00 in a research note on Wednesday. The Goldman Sachs Group assumed coverage on Axon Enterprise in a research note on Tuesday, March 7th. They set a “buy” rating and a $263.00 target price for the company. Needham & Company LLC reiterated a “buy” rating and set a $240.00 target price on shares of Axon Enterprise in a research note on Thursday, April 13th. JMP Securities restated a “market outperform” rating and issued a $235.00 price target on shares of Axon Enterprise in a research note on Friday, April 14th. Finally, StockNews.com began coverage on Axon Enterprise in a research note on Thursday, March 16th. They issued a “hold” rating for the company.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 39,119 shares of Axon Enterprise stock in a transaction on Tuesday, March 28th. The stock was sold at an average price of $215.81, for a total value of $8,442,271.39. Following the completion of the transaction, the chief executive officer now directly owns 2,798,701 shares of the company’s stock, valued at approximately $603,987,662.81. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Axon Enterprise news, CEO Patrick W. Smith sold 53,431 shares of Axon Enterprise stock in a transaction on Thursday, March 30th. The stock was sold at an average price of $217.35, for a total value of $11,613,227.85. Following the completion of the transaction, the chief executive officer now directly owns 2,883,023 shares of the company’s stock, valued at approximately $626,625,049.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Patrick W. Smith sold 39,119 shares of the business’s stock in a transaction on Tuesday, March 28th. The stock was sold at an average price of $215.81, for a total value of $8,442,271.39. Following the transaction, the chief executive officer now directly owns 2,798,701 shares of the company’s stock, valued at approximately $603,987,662.81. The disclosure for this sale can be found here. Insiders sold 99,290 shares of company stock valued at $21,547,805 in the last three months. Corporate insiders own 6.90% of the company’s stock.

Hedge Funds Weigh In On Axon Enterprise

Institutional investors have recently modified their holdings of the business. Meritage Portfolio Management acquired a new position in shares of Axon Enterprise during the 4th quarter worth $249,000. American Trust increased its holdings in Axon Enterprise by 4.8% in the 3rd quarter. American Trust now owns 4,400 shares of the biotechnology company’s stock worth $509,000 after purchasing an additional 200 shares in the last quarter. Griffin Asset Management Inc. acquired a new position in Axon Enterprise in the 4th quarter worth about $237,000. SG Americas Securities LLC increased its holdings in Axon Enterprise by 1,390.9% in the 4th quarter. SG Americas Securities LLC now owns 20,843 shares of the biotechnology company’s stock worth $3,458,000 after purchasing an additional 19,445 shares in the last quarter. Finally, Mitsubishi UFJ Trust & Banking Corp increased its holdings in Axon Enterprise by 0.5% in the 3rd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 123,539 shares of the biotechnology company’s stock worth $14,300,000 after purchasing an additional 600 shares in the last quarter. Institutional investors and hedge funds own 75.62% of the company’s stock.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $192.73 on Thursday. The company has a current ratio of 3.00, a quick ratio of 2.66 and a debt-to-equity ratio of 0.53. Axon Enterprise has a 12 month low of $82.49 and a 12 month high of $229.95. The stock has a 50 day moving average of $218.88 and a 200-day moving average of $194.26. The company has a market capitalization of $14.24 billion, a P/E ratio of 94.48 and a beta of 0.95.

About Axon Enterprise

(Get Rating)

Axon Enterprise, Inc engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services.